Speakers

James Miskin

Chief Technical Officer  • Oxford BioMedica (UK) Ltd

Dr Miskin joined Oxford Biomedica in 2000. He has more than 17 years experience in the GxP environment. In his current role, he has overall responsibility for Oxford Biomedica’s Quality systems, analytical testing, lentiviral based bioprocessing development and client programmes. He is also a named inventor on several patents in the field. He holds a Bachelor of Science degree and a PhD in Molecular Biology from the University of Leeds and subsequently conducted post-doctoral research at The Pirbright Institute for a number of years. He is an active member of the UK BioIndustry Association Manufacturing Advisory Committee and is the Advanced Therapies work stream lead for The Medicines Manufacturing Industry Partnership (MMIP)

Also Speaking

Andy Holt

Chief Commercial Officer • Cellistic

Peter Zandstra

Professor • University of British Columbia

Gwen Nichols

Chief Medical Officer • The Leukemia & Lymphoma Society

Event Info

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.
Image

2025 Event Brochure

Download the event brochure for Advanced Therapies Week 2025.